Page last updated: 2024-11-07

n-acetyl-s-farnesylcysteine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-acetyl-S-farnesylcysteine: inhibits prenyl-cysteine carboxyl methyl transferases [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6438381
CHEMBL ID1555989
CHEBI ID166669
CHEBI ID94750
MeSH IDM0186775

Synonyms (62)

Synonym
CHEBI:166669
acetyl-farnesyl-cysteine
135304-07-3
(2r)-2-acetamido-3-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulanylpropanoic acid
BRD-K79437791-001-02-4
arazine
afc medirepair
BSPBIO_001384
IDI1_033854
IDI1_033967
SPECTRUM5_001957
NCGC00161311-03
NCGC00161311-02
NCGC00161311-01
n-afc
l-cysteine, n-acetyl-s-(3,7,11-trimethyl-2,6,10-dodecatrienyl)-, (e,e)-
n-acetyl-s-trans,trans-farnesyl-l-cysteine
n-acetyl-s-farnesylcysteine
afc cpd
NCGC00161311-04
HMS1989K19
HMS1989F06
n-acetyl-l-farnesylcysteine
BML2-C11
HMS1791F06
HMS1791K19
HMS1361F06
HMS1361K19
(2r)-2-acetamido-3-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylpropanoic acid
kk6984c8o3 ,
unii-kk6984c8o3
l-cysteine,n-acetyl-s-[(2e,6e)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl]-
CHEMBL1555989 ,
acetylfarnesylcysteine
n-acetyl-l-farnesylcysteine [mi]
acetyl farnesylcysteine [inci]
l-cysteine, n-acetyl-s-((2e,6e)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl)-
l-cysteine, n-acetyl-s-((2e,6e)-3,7,11-trimethyl-2,6,10-dodecatrienyl)-
acetyl farnesylcysteine
G-200
ac-cys(farnesyl)-oh
FD21323
(2r)-2-acetamido-3-[[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trienyl]thio]propionic acid
HMS3649I07
HMS3402F06
mfcd00871540
(r)-2-acetamido-3-(((2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)thio)propanoic acid
AKOS027327980
CHEBI:94750
XTURYZYJYQRJDO-BNAHBJSTSA-N
n-acetyl-s-(e,e)-farnesyl-l-cysteine
acetyl (n)-s-farnesyl-l-cysteine
BCP18226
HY-133021
CS-0109433
AS-49038
sr-05000002098
SR-05000002098-2
Q27282303
(r)-2-acetamido-3-(((2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)thio)propanoicacid
bdbm50530481
DTXSID701021741
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
sesquiterpenoidAny terpenoid derived from a sesquiterpene. The term includes compounds in which the C15 skeleton of the parent sesquiterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
phosphopantetheinyl transferaseBacillus subtilisPotency56.23410.141337.9142100.0000AID1490
Microtubule-associated protein tauHomo sapiens (human)Potency39.81070.180013.557439.8107AID1460
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency47.39350.354828.065989.1251AID504847
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency28.18380.251215.843239.8107AID504327
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Bifunctional epoxide hydrolase 2Homo sapiens (human)IC50 (µMol)200.68000.00000.54509.1000AID1615721; AID1615722; AID1615730
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (8)

Processvia Protein(s)Taxonomy
response to toxic substanceBifunctional epoxide hydrolase 2Homo sapiens (human)
positive regulation of gene expressionBifunctional epoxide hydrolase 2Homo sapiens (human)
dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
cholesterol homeostasisBifunctional epoxide hydrolase 2Homo sapiens (human)
stilbene catabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
phospholipid dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
regulation of cholesterol metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
magnesium ion bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide hydrolase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
toxic substance bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lipid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
protein homodimerization activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lysophosphatidic acid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomal matrixBifunctional epoxide hydrolase 2Homo sapiens (human)
cytosolBifunctional epoxide hydrolase 2Homo sapiens (human)
extracellular exosomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1615722Inhibition of phosphatase activity of full length human soluble epoxide hydrolase pre-incubated for 30 mins before FDP substrate addition by fluorescence based assay2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
AID1615721Inhibition of hydrolase activity of full length human soluble epoxide hydrolase pre-incubated for 30 mins before PHOME substrate addition by fluorescence based assay2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
AID1615730Inhibition of hexa-His-tagged human soluble epoxide hydrolase C-terminal hydrolase domain expressed in Escherichia coli BL21(DE3) pre-incubated for 30 mins before DiFMUP substrate addition by fluorescence based assay2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
AID1615729Induction of stabilization of hexa-His-tagged human soluble epoxide hydrolase N-terminal phosphatase domain expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 50 uM by differential scanning fluorimetry2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
AID1615708Inhibition of hexa-His-tagged human soluble epoxide hydrolase N-terminal phosphatase domain expressed in Escherichia coli BL21(DE3) pre-incubated for 30 mins before FDP substrate addition by fluorescence based assay2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
AID643000Inhibition of His-tagged human Icmt membrane protein over-expressed in Saccharomyces cerevisiae 2766 using [14C]-SAM and N-acetyl-S-farnesyl-l-cysteine as substrate measured after 30 mins by scintillation counting2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Amide-modified prenylcysteine based Icmt inhibitors: Structure-activity relationships, kinetic analysis and cellular characterization.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (42)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's22 (52.38)18.2507
2000's13 (30.95)29.6817
2010's7 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other42 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]